Drug
Inhaled mannitol
Inhaled mannitol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_3
3
60%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (40.0%)
Phase 33 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
NCT02134353
completedphase_3
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
NCT00630812
completedphase_3
Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis
NCT00669331
completedphase_2
Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years
NCT01883531
completedphase_2
A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis
NCT00455130
Clinical Trials (5)
Showing 5 of 5 trials
NCT02134353Phase 3
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
NCT00630812Phase 3
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
NCT00669331Phase 3
Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis
NCT01883531Phase 2
Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years
NCT00455130Phase 2
A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5